Indeed, AChE inhibitors have positive effects on a variety of behavioral and psychiatric symptoms in AD, particularly for apathy, depression and anxiety [37]; these symptoms are often associated with low physical activity and physical deconditioning, which may impact on the ability to walk in the longer-term. This evidence concerns the gene ACHE and major depressive disorder.